Prostate Cancer Clinical Trials in Anaheim, CA

Prostate Cancer Clinical Trials in Anaheim, CA

View the best 10 prostate cancer medical studies in Anaheim, California. Access promising new therapies by applying to a Anaheim-based Prostate Cancer clinical trial.

Top rated prostate cancer clinical trials in Anaheim, California

Here are the top 10 medical studies for prostate cancer in Anaheim, California

Image of Urological Associates of Southern Arizona, P.C . in Tucson, United States.

PF-06821497

BCL-2 Inhibitor

Recruiting1 awardPhase 1
This trial is testing a new drug to treat adult patients with small cell lung cancer, castration resistant prostate cancer, or follicular lymphoma who have relapsed or are refractory to standard therapies.
Image of Research Site in Lakewood, United States.

Capivasertib +1 More

AKT Inhibitor

Recruiting1 awardPhase 3
This trial will compare the efficacy of capivasertib+abiraterone+androgen deprivation therapy to placebo+abiraterone+androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer (mHSPC) whose tumours are PTEN-deficient. The primary endpoint is radiographic progression-free survival.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Capivasertib +18 More

Kinase Inhibitor

Recruiting1 awardPhase 2
This trial uses genomic testing to direct cancer treatment. Patients with cancer that has progressed after standard treatment or for which there is no agreed-upon treatment may benefit.
Image of St. Joseph Heritage Healthcare ( Site 0069) in Fullerton, United States.

Pembrolizumab +1 More

Checkpoint Inhibitor

Recruiting1 awardPhase 3
This trial will test whether a combination of two drugs is better than one of the drugs alone at treating prostate cancer that has spread and is resistant to hormone therapy.
Image of Orange Coast Memorial Medical Center in Fountain Valley, United States.

CyberKnife

Proton Beam Therapy

Recruiting1 award
This trial will test the effectiveness of CyberKnife SABR in treating prostate cancer while also monitoring for side effects.
Image of Tibor Rubin VA Medical Center in Long Beach, United States.

Hormone Therapy

Recruiting2 awardsPhase 3
This trial is testing whether adding apalutamide to the standard treatment of surgery and radiation therapy can improve outcomes for patients with lymph node positive prostate cancer.
Image of Sarah Cannon Research Institute MCC in Asheville, United States.

Enzalutamide

Androgen Receptor Inhibitor

Recruiting1 awardPhase 2
This trial is testing a new drug, ZEN003694, to see if it is more effective than the current standard of care, enzalutamide, in patients with metastatic castration-resistant prostate cancer (mCRPC) who have progressed on prior abiraterone. Patients will be randomized to receive either ZEN003694 in combination with enzalutamide or enzalutamide monotherapy. The primary endpoint is radiographic progression-free survival (rPFS) by PCWG3 criteria.
Image of Arizona Center for Cancer Care - Gilbert in Gilbert, United States.

ProstAtak® Immunotherapy

Cancer Vaccine

Recruiting1 awardPhase 3
This trial is testing whether adding ProstAtak immunotherapy to radiation therapy can improve outcomes for patients with localized prostate cancer at high or intermediate risk for the disease coming back.
Image of University of California at Davis in Davis, United States.

ONC-392 +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 1 & 2
This trial is testing a new drug, ONC-392, as a possible treatment for advanced or metastatic solid tumors and non-small cell lung cancers. The trial will test different doses of the drug to see what is safe and what works best. The trial will also test ONC-392 in combination with another drug, pembrolizumab.
Image of USC Norris Comprehensive Cancer Center in Los Angeles, United States.

dietary intervention

Recruiting1 award
This trial looks at whether a low calorie diet can help reduce side effects and improve response to chemo for breast or prostate cancer patients.

Popular filter options for prostate-cancer anaheim trials

Phase 3 Clinical Trials

View 100 phase 3 medical studies.

Clinical Trials With No Placebo

View 100 medical studies that do not have a placebo group.

View More Prostate-cancer Anaheim Trials

See another 83 medical studies focused on prostate-cancer anaheim.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.